<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=348185225613720&amp;ev=PageView&amp;noscript=1">
Skip to content
10015-D_Oncology-Week_LP-Hero-Med1@3x

Explore how genomics can transform oncology research as we showcase the latest advancements in genomics tools and their role in revolutionizing cancer screening and treatment. Through our webinars, live discussions, and grants, learn how these tools can help decode the genetic mysteries of cancer, lead to more precise diagnoses and personalized treatments, and pave the way toward a healthier, cancer-free future. Together, we can advance oncology research and make a difference in the lives of those affected by cancer.

WEBINARS

Register now to improve difficult sample processing and streamline viral-vector development for cancer therapeutics

Browse Webinars >

LIVE DISCUSSIONS

Join industry experts for a live discussion on improving MRD detection with cutting-edge NGS tools

Attend the Roundtable >

GRANTS

Enter to win one of four grants totaling $25,000 as we recognize excellence in oncology research

 

Apply Now >

MicrosoftTeams-image (32)Webinars

NOW AVAILABLE ON DEMAND

FFPE and Liquid Biopsy Multiomics: Solutions for Difficult Samples

AOHara

Andrea O’Hara, Ph.D.

Senior Product Manager

Azenta Life Sciences

Discover how to unlock critical insights hidden in Formalin-Fixed Paraffin-Embedded (FFPE) tissue samples and liquid biopsies to support oncology research.

NOW AVAILABLE ON DEMAND

Viral-Vector Solutions: Enhancing the Development of Cell & Gene Therapy Treatments

ELouie

Elizabeth (Liz) Louie, Ph.D.

Manager, Technical Applications

Azenta Life Sciences

Explore the recent advancements of various viral-vector technologies and how to leverage these updates for the successful development of personalized cancer therapies.

MicrosoftTeams-image (33)Live Discussions

ROUNDTABLE

From Bench to Bedside: Advancing MRD Detection with Cutting-Edge NGS Tools

NOW AVAILABLE ON DEMAND

Join four industry experts as they discuss advancements in next generation sequencing (NGS) tools and how they can accelerate oncology research. Topics will include how ultra-sensitive NGS can help detect minimal residual disease (MRD); how researchers are optimizing downstream analysis for oncology samples; pros and cons of targeted panels as a standard of care for different types of cancer.

GBelgard

T. Grant Belgard, Ph.D.

CEO

The Bioinformatics CRO

AWoodward

Alexa Woodward, Ph.D.

Partnerships and Strategy Manager

Optum

JTio

Jeff Tio, Ph.D.

Director, Integrated Solutions

Azenta Life Sciences

ELouie

Elizabeth (Liz) Louie, Ph.D.

Manager, Technical Applications

Azenta Life Sciences

MicrosoftTeams-image (31)Grants

APPLY BY THURSDAY, MAY 24, 2024

Enter to win one of four grants totaling $25,000*

Streamlining your journey towards discovering a healthier, cancer-free future starts here! Our Oncology Insights Grant Program – totaling $25,000 – features awards spanning gene synthesis, precision antibody discovery using machine learning, next generation sequencing (NGS), and Olink® proteomics.

Submit your abstract by May 24, 2024 to be considered for one of four oncology-focused grants to help advance your discoveries.

*Contest rules and regulations apply

Never miss an update

Get the latest event updates, industry trends, and best practices straight to your inbox to help bring your research to market faster.